Q2 INTERIM REPORT April-June 2024

Mentice has received a 2.26 million USD order for simulation solutions from a top 20 global MedTech company

Mentice receives an order of USD 655,000 for simulation solutions from Medtronic

Thursday, March 2, 2023

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® and physiological flow system simulation solutions for 655,000 USD.

"We are proud that Medtronic has chosen Mentice solutions to support their educational training facility at Medtronic Innovation Center in Istanbul, Turkey,” says Göran Malmberg, the CEO of Mentice. “By utilizing Mentice procedural and device adoption solutions, physicians will have access to the most advanced hands-on learning solutions on the market."

The order will be accounted for in the order book for the business area Medical Device Industry during the second quarter of 2023.

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB